August 2012 Issue - Endovascular Today

Table of Contents

Issue

August 2012

The Data Demand

Examining lessons learned as new results emerge across the spectrum of SFA therapies.

Supplement

Innovations in The Art of Stent Grafting

Utilizing the GORE^® VIABAHN^® Endoprosthesis to treat complex SFA and iliac artery disease.

In This Issue

Chief Medical Editor's Page

The Demand for SFA Data

By John R. Laird, MD

Cover Stories

Randomized Trials and Registries of Superficial Femoral Artery Stenting

The current data and future directions of SFA stenting technology.

By Ehrin J. Armstrong, MD, John R. Laird, MD

Informing Our Atherectomy Decisions

New data and specialized technologies are emerging, but where do we still need information?

By Lawrence A. Garcia, MD

Drug-Coated Balloons: Hope or Hype?

A stentless technology is an attractive option if it achieves at least as good acute and long-term results as current devices in the femoropopliteal artery.

By Thomas Zeller, MD

Mechanisms of Action in Drug-Coated Balloons

Insights into the clinical safety and efficacy of this emerging technology.

By Maxwell E. Afari, MD, and Juan F. Granada, MD, FACC

One Question… How Will You Apply Drug-eluting Stents in Your SFA Practice?

Featuring Gary M. Ansel, MD; Bruce H. Gray, DO, MSVM, FSCAI; John H. Rundback, MD; and Evan Lipsitz, MD

Managing the Claudicant: Are We Too Aggressive?

Some healthy introspection based on the current literature.

By Eanas S. Yassa, MD, and Joseph V. Lombardi, MD

Techniques

Treatment of Peripheral Arterial Disease Using Rotational Atherectomy

The shift to endovascular therapy continues to grow. A case review and discussion.

By Dorian J. deFreitas, MD, and Joseph J. Ricotta II, MD, MS

Staged Endovascular Repair Resulting in Renal Salvage

Endovascular management of a renal artery aneurysm with large arteriovenous fistula and giant venous aneurysm.

By Rupal Bandi, MD, and Yun Robert Sheu, MD, MS

Departments

Innovations

An Interview with William Hiatt, MD

A leading TASC author discusses the value and challenges in establishing guidelines, goals for TASC III, exercise therapy, and the FDA's advisory committee processes.

August 2012 Supplement

Innovations in The Art of Stent Grafting

Utilizing the GORE^® VIABAHN^® Endoprosthesis to treat complex SFA and iliac artery disease.

In This Issue

August 2012 Supplement

Most Read Articles